Local Institution - 106

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Completed